Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.
about
Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolatesA Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-AnalysisPrimary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factorsCombined Whole-Cell High-Throughput Functional Screening for Identification of New Nicotinamidases/Pyrazinamidases in Metagenomic/Polygenomic LibrariesReevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.Microbial genomics and antimicrobial susceptibility testing.Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for actionA Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis.Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in GeorgiaThe pyrazinamide susceptibility breakpoint above which combination therapy fails.Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, ChinaInvestigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological studyCounting pyrazinamide in regimens for multidrug-resistant tuberculosisMechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomographyPyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.Tuberculosis and HIV co-infection, California, USA, 1993–2008.High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis.Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosisRole of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China.Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria.Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite?'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibilityPrevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in ChinaPrevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis.Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA.A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.Evaluation of a biphasic media assay for pyrazinamide drug susceptibility testing of Mycobacterium tuberculosis.Reply to "role of rpsA gene sequencing in diagnosis of pyrazinamide resistance"Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modellingHalf of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.Drug resistance mechanism of PncA in Mycobacterium tuberculosis.Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?Using Reduced Inoculum Densities of Mycobacterium tuberculosis in MGIT Pyrazinamide Susceptibility Testing to Prevent False-Resistant Results and Improve Accuracy: A Multicenter Evaluation.Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.
P2860
Q27004697-722F27C6-FA33-43A1-8355-295C8E983F6CQ27011264-68C1CFC5-A6E6-4309-84A8-3FD88D2AC666Q28535281-658299CD-C047-42C8-B82D-F359ED99E944Q28817696-EB9F7CEC-3D68-4BB7-AB97-EB56A67E0C87Q30224832-15845418-1479-4B66-A642-8B45A4AB40DFQ30397574-B60A5581-66DA-491D-8767-A54BB3EECEDCQ33576909-7E4034B8-A03E-4DE4-9D7C-82E5B77FB7E0Q33812455-5B4CEE89-F664-4650-A211-505B0ADC915BQ33896434-ED78F5C9-3E2C-483C-A5FB-58A77215C2ACQ34034401-E258A7A4-A31E-4294-B7C6-94E5C08FDF5BQ35076847-38C4487F-9EE1-4170-A6CE-D1247E77C4A7Q35177554-F59C6E52-C53F-41E5-8ED6-B0BBC98AFFFDQ35565162-540ED03A-4238-4CDD-8794-0A15300D1C46Q35566384-3DE3BBF4-8EA3-4599-9CF8-0114359965BFQ35689060-B1DFE649-D02C-4370-B080-E89A1ECF0E59Q36267526-B77B2930-9166-4224-816B-B13AC29FB8BAQ36364095-49618ABE-92FB-4380-8701-D2C06A1908ECQ36829094-47F352E4-87AE-4782-8CEA-FB5ADE536F70Q37023104-F91F2542-B925-493E-9FCE-836847D60F4CQ37074826-CBC16A5E-8A2A-44A5-94EA-711002B3A097Q37133281-A4571681-C3F9-4505-A87C-9693865A0A1DQ37546627-7D3310D4-0E88-4664-9E55-9FD05C9ABCC6Q38040155-6C1556E7-8B10-4776-8C56-030C01D142C2Q38368943-D28B3BDC-4425-4FF9-AB53-4FE30B7C0261Q38494436-DF4FD985-AD69-453C-A5F0-CD6796B5314DQ38514218-103EE54F-2A13-4CF9-A434-EA6EFFF85CA6Q39785436-E21A57F6-A520-425A-89B4-C2A00601F278Q40091081-0849BC2B-B229-4D5F-A882-E5045235B8D0Q40634015-21D58C6A-B20B-43F5-B16D-780B7BC619EEQ41580259-4418447F-0178-4DBB-ABCD-4A78AC6BC3EAQ41701192-056D213C-5BB3-45BC-8A81-C8A13ABE2898Q42127991-2400A890-C542-408B-8B63-D95CA7D5783DQ42209072-D6F5489D-5D33-4ED9-9C62-5616AE480331Q42530822-1A94F3E6-F343-444C-8A03-E44F700DBDADQ42546968-B9DEDD0C-17A1-42C6-94F4-79E1A6BFAC27Q43923911-0EAE89CB-4DE6-4487-8B3E-D670F0557E10Q44227288-9C33D7F0-86A9-4CA6-B2A2-7081C944B180Q45223094-944DEC68-661E-40ED-A6E3-5CFBF2F0A54FQ46765284-046CCB3E-0E61-491E-9360-CF5D8489F49EQ47554066-E228195A-CA08-47B5-B723-611527186229
P2860
Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pyrazinamide susceptibility te ...... tic review with meta-analyses.
@en
Pyrazinamide susceptibility te ...... tic review with meta-analyses.
@nl
type
label
Pyrazinamide susceptibility te ...... tic review with meta-analyses.
@en
Pyrazinamide susceptibility te ...... tic review with meta-analyses.
@nl
prefLabel
Pyrazinamide susceptibility te ...... tic review with meta-analyses.
@en
Pyrazinamide susceptibility te ...... tic review with meta-analyses.
@nl
P2093
P2860
P921
P356
P1476
Pyrazinamide susceptibility te ...... tic review with meta-analyses.
@en
P2093
Kwok Chiu Chang
Wing Wai Yew
Ying Zhang
P2860
P304
P356
10.1128/AAC.00630-11
P407
P577
2011-07-18T00:00:00Z